TyG-CVAI for identifying hyperuricemia: geographical external validation, model updating, and explainable machine learning
- 1Qingdao Municipal Hospital, University of Health and Rehabilitation Sciences
- 2Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences
- 3The Second Affiliated Hospital, Shandong First Medical University & Shandong Academy of Medical Sciences
Abstract
Background: TyG-CVAI can be calculated from routine metabolic and anthropometric measurements, but evidence for same-visit identification of prevalent hyperuricemia across regions, its incremental value beyond conventional variables, and its advantage over the constituent variables themselves remains limited.
Objective: To assess the geographical transportability of the triglyceride-glucose Chinese visceral adiposity index (TyG-CVAI) for identifying prevalent hyperuricemia and to determine whether model updating or more complex machine-learning methods materially improve externally validated performance.
Methods: We analyzed prospectively collected, single-visit health-examination and questionnaire data from 2,119 adults and performed a cross-sectional analysis. The Shandong center was used for model development (n=1,288) and the Jiangsu center for geographical external validation (n=831). Associations were estimated with multivariable logistic regression and robust Poisson regression, with restricted cubic splines for dose-response assessment. Single-index discrimination, transferred thresholds, calibration, decision-curve analysis, five prespecified logistic model formulations, recalibration, reverse validation, and dataset shift were evaluated. Machine-learning models were tuned by nested resampling in Shandong and evaluated once in Jiangsu; serum urate and all outcome-derived variables were excluded from every prediction step.
Results: Hyperuricemia was present in 433 participants (20.43%). A 1-SD increase in TyG-CVAI was associated with higher odds of prevalent hyperuricemia in Shandong (OR, 1.74; 95% CI, 1.39-2.18), Jiangsu (OR, 1.97; 95% CI, 1.50-2.59), and the pooled cohort (OR, 1.84; 95% CI, 1.55-2.19), with no center interaction (P = 0.984). The pooled prevalence ratio per 100-unit increase was 1.12 (95% CI, 1.09-1.16). TyG-CVAI AUCs were 0.74 in Shandong and 0.72 in Jiangsu. Applying the rounded Shandong cutoff of 593 in Jiangsu yielded sensitivity 0.75 and specificity 0.52. The external AUC increased from 0.71 for the noncomponent clinical model to 0.74 after adding TyG-CVAI, but a components-only model achieved 0.74 and the clinical-plus-components model 0.76. Penalized logistic regression had the highest external machine-learning AUC point estimate (0.74), but no tree model differed significantly after multiplicity adjustment. The prespecified sex interaction was not significant after Holm correction.
Conclusions: TyG-CVAI was consistently associated with prevalent hyperuricemia across two centers and showed moderate discrimination. It provided a small increment over a clinical model that deliberately excluded its components, but no clear advantage over models using the constituent variables directly. TyG-CVAI may help prioritize direct serum-urate testing when its components are already available, but it should not be used as a stand-alone diagnostic or prognostic test.
Related
- Explainable machine learning and multivariable logistic regression for identifying prevalent self-reported physician-diagnosed chronic lung disease in postmenopausal women: development and multi-cohort external validation
- An explainable and leakage-aware machine learning model for early risk stratification of radioiodine-refractory differentiated thyroid cancer: development and single-center geographic external validation
- Development and temporal validation of an explainable machine-learning model for identifying anxiety symptoms in adults with sudden sensorineural hearing loss
- Development and external validation of a nomogram for identifying patients with thyroid eye disease who screen positive for depressive symptoms: a two-center study.
- The urate deposition index as a classification tool for identifying subclinical monosodium urate deposition in patients with hyperuricemia
BibTeX
@article{liang2026tygcvai,
title = {{TyG-CVAI for identifying hyperuricemia: geographical external validation, model updating, and explainable machine learning}},
author = {Chen Liang and Zhengyang Lu and Zhengtao Li and Yifan Li},
journal = {Frontiers in Endocrinology},
year = {2026},
month = nov,
doi = {10.3389/fendo.2026.1964421},
url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1964421/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - TyG-CVAI for identifying hyperuricemia: geographical external validation, model updating, and explainable machine learning
AU - Chen Liang
AU - Zhengyang Lu
AU - Zhengtao Li
AU - Yifan Li
PY - 2026
DA - 2026/11/03
JO - Frontiers in Endocrinology
DO - 10.3389/fendo.2026.1964421
UR - https://www.frontiersin.org/articles/10.3389/fendo.2026.1964421/full
AB - Background: TyG-CVAI can be calculated from routine metabolic and anthropometric measurements, but evidence for same-visit identification of prevalent hyperuricemia across regions, its incremental value beyond conventional variables, and its advantage over the constituent variables themselves remains limited. Objective: To assess the geographical transportability of the triglyceride-glucose Chinese visceral adiposity index (TyG-CVAI) for identifying prevalent hyperuricemia and to determine whether model updating or more complex machine-learning methods materially improve externally validated performance. Methods: We analyzed prospectively collected, single-visit health-examination and questionnaire data from 2,119 adults and performed a cross-sectional analysis. The Shandong center was used for model development (n=1,288) and the Jiangsu center for geographical external validation (n=831). Associations were estimated with multivariable logistic regression and robust Poisson regression, with restricted cubic splines for dose-response assessment. Single-index discrimination, transferred thresholds, calibration, decision-curve analysis, five prespecified logistic model formulations, recalibration, reverse validation, and dataset shift were evaluated. Machine-learning models were tuned by nested resampling in Shandong and evaluated once in Jiangsu; serum urate and all outcome-derived variables were excluded from every prediction step. Results: Hyperuricemia was present in 433 participants (20.43%). A 1-SD increase in TyG-CVAI was associated with higher odds of prevalent hyperuricemia in Shandong (OR, 1.74; 95% CI, 1.39-2.18), Jiangsu (OR, 1.97; 95% CI, 1.50-2.59), and the pooled cohort (OR, 1.84; 95% CI, 1.55-2.19), with no center interaction (P = 0.984). The pooled prevalence ratio per 100-unit increase was 1.12 (95% CI, 1.09-1.16). TyG-CVAI AUCs were 0.74 in Shandong and 0.72 in Jiangsu. Applying the rounded Shandong cutoff of 593 in Jiangsu yielded sensitivity 0.75 and specificity 0.52. The external AUC increased from 0.71 for the noncomponent clinical model to 0.74 after adding TyG-CVAI, but a components-only model achieved 0.74 and the clinical-plus-components model 0.76. Penalized logistic regression had the highest external machine-learning AUC point estimate (0.74), but no tree model differed significantly after multiplicity adjustment. The prespecified sex interaction was not significant after Holm correction. Conclusions: TyG-CVAI was consistently associated with prevalent hyperuricemia across two centers and showed moderate discrimination. It provided a small increment over a clinical model that deliberately excluded its components, but no clear advantage over models using the constituent variables directly. TyG-CVAI may help prioritize direct serum-urate testing when its components are already available, but it should not be used as a stand-alone diagnostic or prognostic test.
SN - 1664-2392
ER -